PRELUDE CAPITAL MANAGEMENT, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 233 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2021$959,000
+4.2%
8,950
-0.0%
0.02%
+4.2%
Q3 2021$920,000
+31.6%
8,951
+12.6%
0.02%
+14.3%
Q2 2021$699,000
+421.6%
7,950
+448.3%
0.02%
+250.0%
Q3 2020$134,000
-79.4%
1,450
-82.1%
0.01%
-76.0%
Q4 2019$649,000
+1375.0%
8,100
+1250.0%
0.02%
+1150.0%
Q3 2019$44,000
-93.9%
600
-93.5%
0.00%
-95.2%
Q3 2018$716,000
+215.4%
9,172
+156.3%
0.04%
+200.0%
Q2 2018$227,000
+404.4%
3,579
+496.5%
0.01%
+250.0%
Q4 2017$45,000
+275.0%
600
+155.3%
0.00%
+300.0%
Q2 2017$12,0002350.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders